Biosimilars - Commercial Strategies and Regulatory Guidelines

9 Dec 2013 at Holiday Inn Bloomsbury, London, United Kingdom

Pharmaceuticals/Drug Discovery

Submit new post
Thank you for posting.
Share it:

The purpose of this Masterclass is to examine the regulatory barriers affecting biosimilar markets across Europe and the within the US.

Biosimilar markets are increasingly attracting more interest and are seen as a new industry for some generic companies to exploit, as these companies attempt to adjust to the high competition and low profit margins found in the commodity generics market. Less regulated markets have seen biosimilars take off in recent years; however this is not the case across Europe and the US where regulatory barriers have slowed the development of this industry in these markets.

SMi's masterclass hosted by Interpharm Consultancy, will address the common pitfalls in and around biosimilar regulatory requirements in both Europe and the US. Case study led and extremely informative, Peter Wittner looks to help identify both successful and unsuccessful applications in regards to biosimilar regulatory approval in a bid to better inform attendees of how they might approach.

Contact Fateja Begum
Tel: +44 (0) 20 7827 6184

Category: Conferences

Price: £599

Time: 8:50 am - 1:00 pm

Speaker: Peter Wittner

From: December 09, 2013 00:00
To: December 09, 2013 23:59

Holiday Inn Bloomsbury, Coram Street, WC1N 1HT, London, United Kingdom


Pharmaceuticals/Drug Discovery

Contact email

Submitted by:

evvnt Platform

Are you the organizer?

Get in touch